Yahoo Finance NXP Semiconductors Stock Hits Buy Point On Better-Than-Expected Outlook
NXP Semiconductors beat analyst estimates for earnings and matched views on sales in the first quarter. NXPI stock rose on the news.
NXP Semiconductors beat analyst estimates for earnings and matched views on sales in the first quarter. NXPI stock rose on the news.
New York and Bilbao, Spain, 21 May - US equity research firm Litchfield Hills Research has just published a new analysis of Virtualware (ENXTPA: MLVIR), reiterating its Buy recommendation at $10.00 per share. The report, signed by analyst Theodore R. O'Neill, reaffirms his ‘Buy’ recommendation and highlights the execution of the company's plan to achieve higher recurring revenue through SaaS subscriptions with the VIROO platform, along with its expansion in the US.He notes that ‘VIROO is becomin
Comedy CentralChiefs kicker Harrison Butker has stirred up controversy after a right-wing rant during a commencement speech earlier this month where he complained about abortion rights, “degenerate cultural values” and encouraged the female graduates to focus on getting married and having kids. The subsequent response by Fox News, who claimed Butker had become a victim of outrage since the speech, led The Daily Show host to take note.“Not the advice you want to hear when you’re $100,000 in debt,
Three girls from one of the capital’s most deprived boroughs win scholarships worth £1million between them for Harvard and Princeton
SINGAPORE, May 21, 2024--Notice is hereby given that the 2024 Annual General Meeting of BW LPG Limited ("BW LPG", the "Company", OSE ticker code: "BWLPG.OL", NYSE ticker code: "BWLP") will be conducted as per the details below:
Leading European research labs will receive 2.5 billion euros ($2.72 billion) in funding under the European Chips Act to set up a pilot line to develop and test future generations of advanced computer chips, Belgium's imec said on Wednesday. The European Union's 43 billion euro Chips Act was announced in 2023 to support domestic European chipmaking, a counterbalance to plans by China, the U.S. and other governments to shore up their own industries following shortages during the COVID pandemic. Leuven, Belgium-based research hub imec will host the pilot line for the sub-2 nanometre chips to help European industry, academics and start-ups access chip manufacturing technology that would otherwise be too expensive for any one of them to test or use in development.
SOUTH SAN FRANCISCO, Calif., May 21, 2024--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for inavolisib, an investigational oral therapy, in combination with palbociclib (Ibrance®) and fulvestrant, for the treatment of adult patients with PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor 2-negative, locally advanced or metastatic bre
They operate in places like an airport, a resort, and a distribution center, tucked away from the public eye but close enough for easy access. Skyrocketing child care costs and staffing shortages have complicated arrangements for working parents. Employers, in turn, view their entry into the child care realm as both a competitive advantage and a workplace morale booster.
The remains reveal "rare physical evidence" of human sacrifice, according to researchers.
The car makers used parts made by a supplier banned over alleged links to Chinese forced labour.
Traders are pricing in a big move for Nvidia’s shares after the chipmaker reports earnings on Wednesday, though expectations for volatility are more muted than in the past, U.S. options markets show. Nvidia's options are primed for an 8.7% swing in either direction by Friday, according to data from options analytics firm Trade Alert. While massive by most measures, that implied move would fall far short of the 16.4% jump Nvidia’s shares notched after the company’s most recent quarterly earnings report.
Reports of antisemitic incidents in the UK have seen a 147 per cent increase since 2022
Read what the stars mean for you today, from Gemini to Capricorn
People aren't carrying as much cash as they used to and while a machine tried to fix this problem, it hasn't been well received.
Explore daily insights on the USA TODAY crossword puzzle by Sally Hoelscher. Uncover expert takes and answers in our crossword blog.
Action choreographer Brahim Chab, who recently staged the action sequences for Deve Patel’s “Monkey Man,” has joined the crew of “Blood Passage.” To be directed by The Philippines’ Pedring Lopez, who recently completed the prison drama series “Sellblock.” “Blood Passage” is a martial arts vampire action horror feature set in Southeast Asia. It s tory …
Oslo, 21 May 2024 – DNO ASA, the Norwegian oil and gas operator, today announced it has engaged DNB Markets, part of DNB Bank ASA, and Pareto Securities AS as Global Coordinators and Joint Bookrunners and with Arctic Securities AS as Joint Bookrunner to arrange fixed income investor meetings. Subject to inter alia market conditions and acceptable terms, a new senior unsecured bond issue with a tenor of five years may follow. The contemplated bond will materially have the same terms as DNO04, iss
Saint-Herblain (France), May 21, 2024 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced the appointment of Dr. Hanneke Schuitemaker, Ph.D. as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024. Valneva decided to complement its Executive Team with an accomplished R&D leader to oversee the further evolution of the Company´s R&D portfolio. Specifically, Dr. Schuitemaker will focus on accelerating Valneva’s pre-clinical
Q1 2024 revenue Strong start of the year anddynamic commercial momentum Total revenue growth of +19.6% in constant currencies, reaching € 40.9 millionSolid commercial traction with existing clients and new logosFurther product enhancements and third-party industry analysts’ recognition2024 objectives confirmed Paris, France, May 21, 2024 – Planisware, a leading B2B provider of SaaS in the rapidly growing Project Economy market, announces today its revenue for Q1 2024. Total revenue amounted to €
Ad hoc announcement pursuant to Art. 53 LR Jean-Paul Clozel to retire as CEO and stand for election as Chairman of the Board of DirectorsMathieu Simon to stand for re-election to the Board – taking on the role of Vice-Chairman and Lead Independent DirectorAndré C. Muller, current CFO of Idorsia, to take over the role of CEO as of June 13, 2024 Allschwil, Switzerland – May 21, 2024Idorsia Ltd (SIX: IDIA) today announced changes to the Idorsia Executive Committee (IEC) and will propose changes in
The designation is based on Phase III INAVO120 results, showing the inavolisib-based regimen more than doubled progression-free survival compared with palbociclib and fulvestrant alone in the first-line setting1Approximately 40% of people with HR-positive breast cancer have a PIK3CA mutation and often face poorer prognosis and resistance to endocrine treatment2,3 This is the 29th Breakthrough Therapy Designation for Roche’s oncology portfolio, a testament to our enduring ambition to deliver tran